• Ep, USP Enrofloxacin CAS 93106-60-6
  • Ep, USP Enrofloxacin CAS 93106-60-6
  • Ep, USP Enrofloxacin CAS 93106-60-6
  • Ep, USP Enrofloxacin CAS 93106-60-6
  • Ep, USP Enrofloxacin CAS 93106-60-6

Ep, USP Enrofloxacin CAS 93106-60-6

Varieties: Infectious Disease Prevention Medicine
Component: Chemical Synthetic Drugs
Type: The First Class
Pharmacodynamic Influential Factors: Repeated Medication
Storage Method: Moisture Proof
Veterinary Reg. No.: No
Samples:
US$ 100/kg 1 kg(Min.Order)
| Request Sample
Gold Member Since 2019

Suppliers with verified business licenses

Trading Company, Other

Basic Info.

Model NO.
Enrofloxacin
Appearance
Light Yellow Crystalline Powder
Stock
Yes
Transport Package
Drum
Specification
EP, USP
Trademark
SAMREAL
Origin
China
HS Code
29339900
Production Capacity
100 Tons Per Year

Product Description

Enrofloxacin [93106-60-6]

Identification
Name   Enrofloxacin
Synonyms   1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
 
Molecular Structure   Ep, USP Enrofloxacin CAS 93106-60-6
 
 
Molecular Formula   C19H22FN3O3
Molecular Weight   359.40
CAS Registry Number   93106-60-6
 
Test Items Standard
Appearance Pale yellowish or light yellow crystalline powder
Solubility Practically insoluble in water,freely soluble in methylene chloride,slightly soluble in methanol.
Identification IR:Conforms to the spectrum of enrofloxacin CRS
Appearance of solution Not more opalescent than reference suspension II and not more intensely coloured reference solution GY4.
Impurity A 0.2%
Ralated substance
Impurity B
Impurity C
Unspecified impurity
Total impurity

0.5%
0.2%
0.2%
1.0%
Ralated substances
Ethanol
Isoamyl alcohol
Methanol
Toluene
N,N-dimethylformaminde

200ppm
100ppm
200ppm
100ppm
880ppm
Loss on drying 1.0%
Sulphated ash 0.1%
Heavy metals  20 ppm
Assay(on drying basis) 98.5%~101.5%
 

Overdosage/acute toxicity

It is unlikely that an acute overdose of either compound would result in symptoms more serious than either anorexia or vomiting, but the adverse effects noted above could occur. Dogs receiving 10 times the labeled dosage rate of enrofloxacin for at least 14 days developed only vomiting and anorexia. Death did occur in some dogs when fed 25 times the labeled rate for 11 days, however.

  • Oral LD50: greater than 5000 mg/kg
  • Dermal LD50: greater than 2000 mg/kg
  • Inhalation LD50: greater than 3547 mg/m3 (4-hour exposure)
  • Eye effects: irritant; reversible in less than 7 days. In cats, it can produce sudden onset blindness when administered by injection, as it is retinotoxic
 

Ep, USP Enrofloxacin CAS 93106-60-6Ep, USP Enrofloxacin CAS 93106-60-6Ep, USP Enrofloxacin CAS 93106-60-6

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2019

Suppliers with verified business licenses

Trading Company, Other
Registered Capital
1500000 RMB
Plant Area
101~500 square meters